Rematiq operates as an AI-native platform for automated product compliance in the medical technology sector.
Rematiq has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Rematiq's investors include Project A Ventures, Amino Collective, HelloWorld, Boris Lokschin, Tino Kreüner.
Rematiq is headquartered in Berlin, Germany.
Rematiq operates as an AI-native platform for automated product compliance in the medical technology sector.
Rematiq is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rematiq — Funding & Investors." VCBacked, April 10, 2025, https://www.vcbacked.co/company/rematiq. Accessed July 19, 2026.
VCBacked. (2025). Rematiq — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/rematiq
{{cite web |title=Rematiq — Funding & Investors |url=https://www.vcbacked.co/company/rematiq |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated